Literature DB >> 1624588

Stability of the recombinant hepatitis B core antigen.

N Nath1, K Hickman, S Nowlan, D Shah, J Phillips, S Babler.   

Abstract

The recombinant gene for hepatitis B core antigen (HBcAg) was cloned and expressed, and the protein was purified from Escherichia coli cultures. Purified HBcAg was tested for the effects of various physical and chemical agents on its immunoreactivity by a paramagnetic particle-based enzyme immunoassay. Recombinant HBcAg retained its immunoreactivity when heated at 70 degrees C for 60 min but was inactivated at 85 degrees C in 10 min. It was stable between pHs 5 and 10.5 but not at pHs 2 and 13.5. Treatment with sodium dodecyl sulfate (SDS), ethanol, and methanol caused a significant loss in HBcAg reactivity. The proteolytic enzymes papain and bacterial protease (type VIII from Bacillus licheniformis) degraded HBcAg significantly, but trypsin and chymotrypsin did not. The effect of combined SDS and 2-mercaptoethanol on recombinant HBcAg was an immediate loss in immunoreactivity, followed by rapid recovery to about 50% of the initial level. This level was maintained for 24 to 48 h and was followed by an almost total loss of HBcAg in about 120 h.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624588      PMCID: PMC265347          DOI: 10.1128/jcm.30.6.1617-1619.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Immunochemical and morphological studies of hepatitis B core antigen isolated from the nuclei of hepatocytes.

Authors:  A Budkowska
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

2.  Identification of a dominant immunogenic epitope of the nucleocapsid (HBc) of the hepatitis B virus.

Authors:  J A Waters; T P Jowett; H C Thomas
Journal:  J Med Virol       Date:  1986-05       Impact factor: 2.327

3.  Antibody to hepatitis-B-virus core in man.

Authors:  J H Hoofnagle; R J Gerety; L F Barker
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

4.  Immunological and morphological properties of HBeAg subtypes (HBeAg/1 and HBeAg/2) in hepatitis B virus core particles.

Authors:  H Ohori; N Shimizu; E Yamada; S Onodera; N Ishida
Journal:  J Gen Virol       Date:  1984-02       Impact factor: 3.891

5.  Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood.

Authors:  D E Koziol; P V Holland; D W Alling; J C Melpolder; R E Solomon; R H Purcell; L M Hudson; F J Shoup; H Krakauer; H J Alter
Journal:  Ann Intern Med       Date:  1986-04       Impact factor: 25.391

6.  Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis.

Authors:  S Stahl; P MacKay; M Magazin; S A Bruce; K Murray
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons.

Authors:  A Miyanohara; T Imamura; M Araki; K Sugawara; N Ohtomo; K Matsubara
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

8.  Hepatitis B virus genes and their expression in E. coli.

Authors:  M Pasek; T Goto; W Gilbert; B Zink; H Schaller; P MacKay; G Leadbetter; K Murray
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

9.  HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation.

Authors:  B Möller; U Hopf; R Stemerowicz; G Henze; H Gelderblom
Journal:  Hepatology       Date:  1989-08       Impact factor: 17.425

10.  The conversion of hepatitis B core antigen synthesized in E coli into e antigen.

Authors:  P MacKay; J Lees; K Murray
Journal:  J Med Virol       Date:  1981       Impact factor: 2.327

View more
  5 in total

1.  Novel double-antigen sandwich immunoassay for human hepatitis B core antibody.

Authors:  An Li; Quan Yuan; Zhiyin Huang; Jian Fan; Ruyi Guo; Bin Lou; Qin Zheng; Shengxiang Ge; Yixin Chen; Zhijun Su; Anthony E T Yeo; Yu Chen; Jun Zhang; Ningshao Xia
Journal:  Clin Vaccine Immunol       Date:  2010-01-27

2.  Microencapsulation of hepatitis B core antigen for vaccine preparation.

Authors:  T Uchida; K Shiosaki; Y Nakada; K Fukada; Y Eda; S Tokiyoshi; N Nagareya; K Matsuyama
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

3.  Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.

Authors:  Tracy D Reynolds; Linda Buonocore; Nina F Rose; John K Rose; Michael D Robek
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

4.  Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide.

Authors:  Jens Schumacher; Tijana Bacic; René Staritzbichler; Matin Daneschdar; Thorsten Klamp; Philipp Arnold; Sabrina Jägle; Özlem Türeci; Jürgen Markl; Ugur Sahin
Journal:  J Nanobiotechnology       Date:  2018-04-13       Impact factor: 10.435

5.  An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis.

Authors:  Sebastian Aston-Deaville; Emil Carlsson; Muhammad Saleem; Angela Thistlethwaite; Hannah Chan; Sunil Maharjan; Alessandra Facchetti; Ian M Feavers; C Alistair Siebert; Richard F Collins; Alan Roseman; Jeremy P Derrick
Journal:  Vaccine       Date:  2020-03-13       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.